December 3, 2015
ARLINGTON, Va. — HDMA’s Center for Healthcare Supply Chain Research has published the latest edition of its annual benchmarking publication, Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2015 Edition). The seventh edition is sponsored by CuraScript Specialty Distribution; Genentech, A Member of the Roche Group; and Pharmacy First.
HDMA’s Center for Healthcare Supply Chain Research has published the latest edition of its annual benchmarking publication, Specialty Pharmaceutical Distribution: Facts, Figures and Trends (2015 Edition). The seventh edition is sponsored by CuraScript Specialty Distribution; Genentech, A Member of the Roche Group; and Pharmacy First.
The publication highlights major characteristics of the specialty pharmaceutical segment — valued at $124 billion in the U.S. in 2014 ($228 billion globally), according to IMS Heath. Formulated for patients with chronic or rare diseases, specialty products typically require special handling, storage, delivery and regulations; the book details the vital role that specialty distributors play to support the safe and efficient delivery of these complex medications. It also highlights the various distribution models, payer influences on the segment, the evolving role of biosimilars and the continued growth of oncology products.
Along with secondary data from leading healthcare organizations, primary survey data were collected from HDMA-member specialty distributors, which currently manage 40 percent of the total U.S. specialty volume handled by distributors and reported sales of $1 billion or more in 2014. Among the findings reported for 2014:
“The Center is pleased to add the latest edition of this publication to its growing body of research on this unique pharmaceutical segment,” said Karen J. Ribler, Executive Vice President and COO of the Center for Healthcare Supply Chain Research. “As noted in this new edition, specialty distributors continued to provide extraordinary service levels to their manufacturer and dispenser trading partners, creating overall supply chain efficiencies.”
Specialty Pharmaceutical Distribution: Facts, Figures and Trends may be downloaded for $250 as a single-use PDF from E-junkie.com. Team and corporate-use licenses also are available. Visit the Center website for further details.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.